Activity Number
Title
Sponsor(s)
Type
Location
CE_02C
Design and Analysis of Noninferiority Trials
ASA
Biopharmaceutical Section
Continuing Education Course
Sat, 8/3
8:30 AM to
5:00 PM
Room: W-Ville-Marie
16
*
Censoring Issues in Survival Analysis
Biopharmaceutical Section
International Chinese Statistical Association
Biometrics Section
Topic Contributed Papers
Sun, 8/4
2:00 PM to
3:50 PM
Room: CC-511b
17
*
Clinical Trials: Recent Advances in Evidence-Based Designs and Challenges
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Sun, 8/4
2:00 PM to
3:50 PM
Room: CC-511a
25
*
Statistical Issues in Assessing Performance of Diagnostic Devices
Section on Statistics in Epidemiology
Biopharmaceutical Section
ASA Special Interest Group for Medical Devices and Diagnostics
Topic Contributed Papers
Sun, 8/4
2:00 PM to
3:50 PM
Room: CC-512f
31
Methodology for Early-Stage Oncology Trials
Biopharmaceutical Section
Biometrics Section
Korean International Statistical Society
Contributed Papers
Sun, 8/4
2:00 PM to
3:50 PM
Room: CC-512g
32
*
Analysis of Safety Data and Rare Events
Biopharmaceutical Section
Korean International Statistical Society
Contributed Papers
Sun, 8/4
2:00 PM to
3:50 PM
Room: CC-512h
53
*
Regulatory Considerations on Design and Analysis of Observational Studies
Biopharmaceutical Section
Biometrics Section
Section on Statistics in Epidemiology
Scientific and Public Affairs Advisory Committee
Invited Papers
Sun, 8/4
4:00 PM to
5:50 PM
Room: CC-511c
60
*
Subgroup Identification for Patients with Enhanced Treatment Response
Section on Statistical Learning and Data Mining
International Chinese Statistical Association
Biometrics Section
Section on Statistics in Epidemiology
Biopharmaceutical Section
Topic Contributed Papers
Sun, 8/4
4:00 PM to
5:50 PM
Room: CC-524b
67
* !
Enhanced Design, Analysis, Modeling, and Interpretation of QT Studies
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Sun, 8/4
4:00 PM to
5:50 PM
Room: CC-512e
69
*
Statistical Analysis Methods with Application to Comparative Effectiveness Research
Biopharmaceutical Section
Biometrics Section
Health Policy Statistics Section
Section for Statistical Programmers and Analysts
Section on Statistics in Epidemiology
Scientific and Public Affairs Advisory Committee
Topic Contributed Papers
Sun, 8/4
4:00 PM to
5:50 PM
Room: CC-512ab
80
*
Biomarkers and Personalized Medicine
Biopharmaceutical Section
Mental Health Statistics Section
International Chinese Statistical Association
Biometrics Section
Contributed Papers
Sun, 8/4
4:00 PM to
5:50 PM
Room: CC-513a
209347
Biopharmaceutical Section Executive Committee Meeting
Biopharmaceutical Section
Other Cmte/Business
Mon, 8/5
7:30 AM to
12:30 PM
Room: I-Maisonneuve
117
*
The Analysis of Recurrent Event Data in the Presence of Competing Risks and Informative Censoring
Biopharmaceutical Section
SSC
Biometrics Section
Topic Contributed Papers
Mon, 8/5
8:30 AM to
10:20 AM
Room: CC-516a
122
*
Patient Report Outcome and Biomarkers in Asthma
Biometrics Section
Biopharmaceutical Section
Section on Statistical Consulting
Health Policy Statistics Section
Korean International Statistical Society
Topic Contributed Papers
Mon, 8/5
8:30 AM to
10:20 AM
Room: CC-511b
130
*
Statistical Issues in Personalized Medicine
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Contributed Papers
Mon, 8/5
8:30 AM to
10:20 AM
Room: CC-513b
133
Statistical Topics in Non-Clinical Studies
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Mon, 8/5
8:30 AM to
10:20 AM
Room: CC-513a
CE_14C
Analysis of Clinical Trials: Theory and Applications
Biopharmaceutical Section
ASA
Continuing Education Course
Mon, 8/5
8:30 AM to
5:00 PM
Room: W-Fortifications
147
*
Recent Advances in Dose-Finding Methods Addressing Practical Issues
ENAR
Biopharmaceutical Section
Biometrics Section
Invited Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-511c
163
*
Enrichment Clinical Trials: Design, Implementation, and Regulatory Perspectives
Biopharmaceutical Section
Mental Health Statistics Section
International Chinese Statistical Association
Biometrics Section
International Indian Statistical Association
Scientific and Public Affairs Advisory Committee
Topic Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-511b
170
*
Issues in Building Imputation Models for Missing Data Techniques
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-514a
175
*
Clinical Trials
Biometrics Section
Biopharmaceutical Section
Korean International Statistical Society
Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-512f
177
Statistical Methods in Oncology Trials and Studies
Biopharmaceutical Section
Biometrics Section
Section for Statistical Programmers and Analysts
Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-514b
178
Bayesian Methods in Early-Phase Clinical Trials
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
International Chinese Statistical Association
Biometrics Section
Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-512ab
179
Topics in Bioequivalence and Biosimilarity
Biopharmaceutical Section
Contributed Papers
Mon, 8/5
10:30 AM to
12:20 PM
Room: CC-514c
197
Biopharmaceutical Section P.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables PM Roundtable Discussion
Mon, 8/5
12:30 PM to
1:50 PM
Room: CC-517d
208
* !
Impact of Bayesian Methods in Medical Product Development
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
ASA Special Interest Group for Medical Devices and Diagnostics
Pharmaceutical Statistics
Invited Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-516d
226
*
Translation of Innovative Dose-Finding Designs Into Phase I Trials
Biometrics Section
Biopharmaceutical Section
Topic Contributed Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-511f
228
*
Future Evolution of Data Monitoring Committees
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-516c
229
Pharmacogenomics: Statistical Challenges and Opportunities on the Journey to Personalized Medicine
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-516a
242
*
Methods for Dealing with Missing Data
Biopharmaceutical Section
International Indian Statistical Association
Section for Statistical Programmers and Analysts
Contributed Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-512ab
244
*
The Analysis of Time-to-Event Data
Biopharmaceutical Section
Biometrics Section
Section for Statistical Programmers and Analysts
Contributed Papers
Mon, 8/5
2:00 PM to
3:50 PM
Room: CC-515c
294
* !
Patient-Reported Outcomes in Mental and Behavioral Health
Mental Health Statistics Section
Biopharmaceutical Section
Health Policy Statistics Section
Section on Statistics in Epidemiology
Scientific and Public Affairs Advisory Committee
Topic Contributed Papers
Tue, 8/6
8:30 AM to
10:20 AM
Room: CC-514a
302
Key Subgroup Analysis Issues in Clinical Trials
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Scientific and Public Affairs Advisory Committee
Topic Contributed Papers
Tue, 8/6
8:30 AM to
10:20 AM
Room: CC-511a
307
*
Bayesian Approaches to Biopharmaceutical Applications
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
Korean International Statistical Society
Contributed Papers
Tue, 8/6
8:30 AM to
10:20 AM
Room: CC-511b
308
Methods for Longitudinal Studies and/or Missing Data
Biopharmaceutical Section
International Chinese Statistical Association
Biometrics Section
Contributed Papers
Tue, 8/6
8:30 AM to
10:20 AM
Room: CC-512ab
321
Methods and Applications in Biomedical Data and Clinical Trials, Part 1
Biopharmaceutical Section
Biometrics Section
Scientific and Public Affairs Advisory Committee
Contributed Papers
Tue, 8/6
8:30 AM to
10:20 AM
Room: CC-516c
326
Critical Aspects of Dose-Finding in Drug Development
Biopharmaceutical Section
Biometrics Section
Invited Papers
Tue, 8/6
10:30 AM to
12:20 PM
Room: CC-513b
339
*
Design of Confirmatory Clinical Trials with Flexibility and Adaptability: Case Studies and Discussions
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
International Indian Statistical Association
Topic Contributed Papers
Tue, 8/6
10:30 AM to
12:20 PM
Room: CC-510d
353
Modeling Clinical Trial Data: PK and Other Applications
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Tue, 8/6
10:30 AM to
12:20 PM
Room: CC-512e
355
*
Statistical Issues in Noninferiority Trials
Biopharmaceutical Section
Biometrics Section
Korean International Statistical Society
Contributed Papers
Tue, 8/6
10:30 AM to
12:20 PM
Room: CC-510b
369
Methods and Applications in Biomedical Data and Clinical Trials, Part 2
Biopharmaceutical Section
Biometrics Section
Scientific and Public Affairs Advisory Committee
Contributed Poster Presentations
Tue, 8/6
10:30 AM to
12:20 PM
Room: CC-220bc
380
Biopharmaceutical Section P.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables PM Roundtable Discussion
Tue, 8/6
12:30 PM to
1:50 PM
Room: CC-517d
407
*
Recent Advances in Design and Analysis of Cancer Clinical Trials
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Tue, 8/6
2:00 PM to
3:50 PM
Room: CC-516a
411
*
Regulatory Challenges in Nonclinical Biostatistics
Biopharmaceutical Section
Biometrics Section
Scientific and Public Affairs Advisory Committee
Topic Contributed Papers
Tue, 8/6
2:00 PM to
3:50 PM
Room: CC-513b
427
* !
Statistical Considerations in Multi-Regional Trials
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Tue, 8/6
2:00 PM to
3:50 PM
Room: CC-514a
428
Statistical Methods for Longitudinal Studies
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Tue, 8/6
2:00 PM to
3:50 PM
Room: CC-514b
209348
Biopharmaceutical Section Business Meeting
Biopharmaceutical Section
Other Cmte/Business
Tue, 8/6
5:30 PM to
7:30 PM
Room: CC-710a
448
Biopharmaceutical Section A.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables AM Roundtable Discussion
Wed, 8/7
7:00 AM to
8:15 AM
Room: CC-517d
465
* !
Highlights of a Special Issue of SBR in Honor of Robert O'Neill's Tenure as Director of the Office of Biostatistics at FDA
Statistics in Biopharmaceutical Research Journal
Biopharmaceutical Section
Invited Papers
Wed, 8/7
8:30 AM to
10:20 AM
Room: CC-510a
468
*
Statistical Innovations Developed for Cancer Clinical Trials
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Wed, 8/7
8:30 AM to
10:20 AM
Room: CC-510b
486
Adaptive Designs: Challenges of Design and Analysis
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Wed, 8/7
8:30 AM to
10:20 AM
Room: CC-510c
487
Challenges in the Evaluation of Biologics
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Wed, 8/7
8:30 AM to
10:20 AM
Room: CC-512c
500
*
The Affordable Healthcare Act's Statistical Challenges
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Health Policy Statistics Section
Section on Statistics in Epidemiology
Scientific and Public Affairs Advisory Committee
Invited Papers
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-512c
518
*
Blinding and Placebo Effects in Randomized Clinical Trials
Biopharmaceutical Section
ASA Special Interest Group for Medical Devices and Diagnostics
Mental Health Statistics Section
Biometrics Section
Section for Statistical Programmers and Analysts
Topic Contributed Papers
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-510a
519
* !
Consistency of Treatment Effects in Multi-Regional Clinical Trials
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-510b
534
Adaptive Designs and Analysis Options
Biopharmaceutical Section
International Chinese Statistical Association
Biometrics Section
Contributed Papers
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-510d
536
Design and Analysis Options for Discrete Data
Biopharmaceutical Section
Contributed Papers
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-512g
547
Contributed Oral Poster Presentations: Biopharmaceutical Section
Biopharmaceutical Section
Contributed Poster Presentations
Wed, 8/7
10:30 AM to
12:20 PM
Room: CC-220bc
554
Biopharmaceutical Section P.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables PM Roundtable Discussion
Wed, 8/7
12:30 PM to
1:50 PM
Room: CC-517d
582
*
Missing Data in Noninferiority Trials
Biopharmaceutical Section
Biometrics Section
Topic Contributed Papers
Wed, 8/7
2:00 PM to
3:50 PM
Room: CC-511f
591
*
Using Historical Information in Clinical Trials: Synthesis of Truth with Uncertainty
Section on Bayesian Statistical Science
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Wed, 8/7
2:00 PM to
3:50 PM
Room: CC-510a
598
*
Randomization Schemes and Their Impacts
Biopharmaceutical Section
Contributed Papers
Wed, 8/7
2:00 PM to
3:50 PM
Room: CC-512g
599
Statistical Methods for Multiplicity
Biopharmaceutical Section
Section on Statistical Graphics
Contributed Papers
Wed, 8/7
2:00 PM to
3:50 PM
Room: CC-511e
624
*
Challenges in Evaluation of Correlates of Protection and Immunobridging in Vaccine Trials
Biopharmaceutical Section
Biometrics Section
Section on Statistics in Epidemiology
Scientific and Public Affairs Advisory Committee
Invited Panel
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-516b
631
* !
Recent Advances in Methodology for CNS Clinical Trials
Biopharmaceutical Section
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-511d
634
* !
Challenges and Advances in Evaluation of Clinical Trials
Biopharmaceutical Section
ASA Special Interest Group for Medical Devices and Diagnostics
Mental Health Statistics Section
Biometrics Section
Topic Contributed Papers
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-511e
646
Challenges of Endpoint Definitions and Interpretation
Biopharmaceutical Section
Mental Health Statistics Section
Contributed Papers
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-513a
647
*
Decisionmaking in Biopharmaceutical Development
Biopharmaceutical Section
Contributed Papers
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-514a
653
Bayesian Clinical Trials
Section on Bayesian Statistical Science
Biopharmaceutical Section
Korean International Statistical Society
Contributed Papers
Thu, 8/8
8:30 AM to
10:20 AM
Room: CC-510d
673
*
Bioequivalence (BE), History, and Developing Ideas
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/8
10:30 AM to
12:20 PM
Room: CC-514c
674
* !
Analyzing Exposure-Adjusted Incident Data in the Clinical Trial Setting
Biometrics Section
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/8
10:30 AM to
12:20 PM
Room: CC-516a
686
Statistical Methods for Adaptive Designs
Biopharmaceutical Section
Biometrics Section
Contributed Papers
Thu, 8/8
10:30 AM to
12:20 PM
Room: CC-511c
687
Methods for Evaluating Diagnostic Tests and/or Agreement
Biopharmaceutical Section
Contributed Papers
Thu, 8/8
10:30 AM to
12:20 PM
Room: CC-514b
688
Novel Regression Methods
Biopharmaceutical Section
Contributed Papers
Thu, 8/8
10:30 AM to
12:20 PM
Room: CC-514a
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Copyright © American Statistical Association.